|
Written by Canuck
|
|
19 March 2009
|
|
This is what I am on once a week... Take from the Vivagloin website....
Vivaglobin® is the first and only FDA-approved
subcutaneous (Sub-Q) immunoglobulin (Ig) therapy available for the
treatment of patients with primary immunodeficiency (PI).
It’s the therapy option that offers your patients greater freedom and flexibility in receiving their Ig replacement therapy.1-3
Vivaglobin® is:
A therapy option to offer your patients with PI
As efficacious as intravenous immunoglobulin (IVIg)
A choice for active patients whose lifestyles demand flexibility
A treatment that patients can administer on their own with your approval
Approved by the FDA in 2006, thousands of US patients have moved beyond their IV therapy to Sub-Q Vivaglobin®. Worldwide, Vivaglobin® has been available for more than 10 years.4
Vivaglobin® is a sterile, ready-to-use, liquid 16% solution of IgG. It is never given intravenously. Instead, Vivaglobin®
is infused into the subcutaneous tissue using an ambulatory infusion
pump or syringe driver. When administered on a weekly basis, it
provides consistent, steady-state serum IgG levels without “wear off”
effects.1,2
Vivaglobin®
can be administered at a doctor’s office, by home care staff, or by
patients, caregivers, or family members. Most adults—and even some
children—can easily learn to administer Vivaglobin® at home—often in just 4 to 6 training sessions. 1-3
Hits: 2356
|